Cargando…

Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches

Systemic sclerosis (SSc) is a systemic disease characterized by autoimmune responses, vasculopathy and tissue fibrosis. The pathogenic mechanisms involve a wide range of cells and soluble factors. The complexity of interactions leads to heterogeneous clinical features in terms of the extent, severit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Elisabetta, Minniti, Antonina, Alexander, Tobias, Del Papa, Nicoletta, Greco, Raffaella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658618/ https://www.ncbi.nlm.nih.gov/pubmed/36359742 http://dx.doi.org/10.3390/cells11213346

Ejemplares similares

Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2018)

Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)
por: Alexander, Tobias, et al.
Publicado: (2022)

Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity
por: Minniti, Antonina, et al.
Publicado: (2020)

Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT
por: Alexander, Tobias, et al.
Publicado: (2021)

Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19
por: Vitali, Claudio, et al.
Publicado: (2020)

Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party
por: Cencioni, Maria Teresa, et al.
Publicado: (2022)

High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

Management of Sjögren's Syndrome: Present Issues and Future Perspectives
por: Vitali, Claudio, et al.
Publicado: (2021)

Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study
por: Del Papa, Nicoletta, et al.
Publicado: (2019)

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
por: Greco, Raffaella, et al.
Publicado: (2021)

Lung Ultrasound to Evaluate Invasive Fungal Diseases after Allogeneic Hematopoietic Stem Cell Transplantation
por: Raffaella, Greco, et al.
Publicado: (2019)

NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity
por: Pignataro, Francesca, et al.
Publicado: (2019)

Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies
por: Cenariu, Diana, et al.
Publicado: (2022)

Instruments for Outcome Evaluation of Specific Domains in Primary Sjögren’s Syndrome
por: Del Papa, Nicoletta, et al.
Publicado: (2021)

Feasibility and toxicity of hematopoietic stem cell transplant in multiple sclerosis
por: Kuan, Thomas Low Tat, et al.
Publicado: (2017)

Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis
por: Thebault, Simon, et al.
Publicado: (2020)

Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis
por: Perram, Jacinta, et al.
Publicado: (2022)

Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
por: Pandit, Awadh Kishor, et al.
Publicado: (2015)

Hematopoietic stem cell transplantation for multiple sclerosis: is it a clinical reality?
por: Bakhuraysah, Maha M., et al.
Publicado: (2016)

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018)

Life after Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
por: Moraes, Daniela A, et al.
Publicado: (2021)

Innovator Filgrastim versus Generic Filgrastim in Hematopoietic Stem Cell Transplantation Mobilization
por: Husian, Sadik, et al.
Publicado: (2021)

Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation
por: Giglio, Fabio, et al.
Publicado: (2022)

Breakthrough Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation
por: Liberatore, Carmine, et al.
Publicado: (2021)

Paired Donor and Recipient Immunophenotyping in Allogeneic Hematopoietic Stem Cell Transplantation: A Cellular Network Approach
por: Wittenbecher, Friedrich, et al.
Publicado: (2022)

Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases
por: Greco, Raffaella, et al.
Publicado: (2023)

Gene Expression Profiles in Primary Sjögren's Syndrome With and Without Systemic Manifestations
por: Vitali, Claudio, et al.
Publicado: (2019)

Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners
por: Farge, D, et al.
Publicado: (2017)

Autologous Hematopoietic Stem Cell Transplantation for Behçet’s Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation
por: Puyade, Mathieu, et al.
Publicado: (2021)

Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children
por: Franca, Raffaella, et al.
Publicado: (2015)

Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study
por: Xue, Elisabetta, et al.
Publicado: (2022)

Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients
por: Noviello, Maddalena, et al.
Publicado: (2023)

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2017)

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
por: Helbig, Grzegorz, et al.
Publicado: (2017)

Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Lycke, Jan, et al.
Publicado: (2020)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi, Reihane, et al.
Publicado: (2021)

B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
por: von Niederhäusern, Valentin, et al.
Publicado: (2022)

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2bi1o5klm79oia825pqv88d91q